OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

On Friday 01/31/2025 the closing price of the Ascentage Pharma Group International Unsponsered American Depository Share share was $17.56 on BTT. Compared to the opening price on Friday 01/31/2025 ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

To get a sense of who is truly in control of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), it is important to understand the ownership structure of the business. With 66% stake, institutions ...

semiconductors and pharmaceuticals in a push to increase U.S. production of the products. Trump announced the moves during remarks at a congressional Republican treat at the Trump National Doral ...

BREAKING: Senate committee advances RFK Jr.'s health secretary nomination to the full floor Featured Shows MSNBC TV More Follow msnbc More Brands More Shows Could the drug ads that flash across ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Ugandan doctors attend the contacts of a patient who had tested positive, during the launch of the vaccination for the Sudan strain of Ebola virus, with a trial vaccine at the Mulago Guest House ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...